Smartphone diagnostic specialist Novarum™ DX has achieved a significant milestone in the development of its revolutionary technology after being officially granted a European patent.
Novarum has been awarded the patent for its smartphone diagnostic technology by the European Patent Office (EPO), having already secured the equivalent patent for its technology in the US earlier this year.
The patents protect Novarums image-capture technology which transforms a smartphone into a diagnostic reader when using the mobiles camera to accurately scan the results of rapid tests.
Since the acquisition by BBI Solutions in 2016, Novarum has expanded its patent portfolio which now includes: China, Japan, Russia, US and Europe with a number of other territories pending.
Novarum Founder and BBI Group Head of Mobile, Dr Neil Polwart said: “The European patent bolsters Novarums position as a leader in smartphone-enabled point of care diagnostics.
“As the second patent to have been awarded this year, were now able to protect our intellectual property across two key territories, the US and Europe.
Our technology corrects misalignments with reading diagnostic tests using the camera feature on a smartphone, without additional hardware, ensuring that our solution is robust in delivering test results of lab quality.
“Our patents safeguard our intellectual property and reaffirm Novarums position as pioneers for next generation diagnostic technologies.”
Novarum DX will attend the leading international trade fair for the medical sector, as MEDICA returns to Düsseldorf, in Germany, this November. As the concept of mHealth (mobile health) continues to gain momentum, Novarum will join the BBI Solutions stand (number 3AC01-1) to showcase how smartphone-enabled point of care technology is revolutionising diagnostic testing.
For more information about Novarum visit:
Exhibitor Data Sheet